Larson Financial Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Larson Financial Group's RYTM Position: Q3 2026 in Review
Larson Financial Group reduced its Rhythm Pharmaceuticals (RYTM) stake by 9.3% in Q3 2026, selling an estimated $1.07K and leaving 97 shares worth $9.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2555.
Larson Financial Group first reported a position in RYTM in Q3 2025 and has held it in 5 quarters since. The position peaked at $11.9K in Q2 2026. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Larson Financial Group held 97 shares of Rhythm Pharmaceuticals worth $9.24K as of Q3 2026.
- Larson Financial Group sold 10 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $1.07K.
- Rhythm Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2555 holding.
- Larson Financial Group first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Larson Financial Group's Rhythm Pharmaceuticals position peaked at $11.9K in Q2 2026.
- 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.